Harbin Medisan Pharmaceutical Co., Ltd. (SHE:002900)

China flag China · Delayed Price · Currency is CNY
11.56
+0.01 (0.09%)
Apr 30, 2026, 3:04 PM CST
5.86%
Market Cap 3.58B
Revenue (ttm) 813.23M
Net Income (ttm) -317.84M
Shares Out 309.54M
EPS (ttm) -0.98
PE Ratio n/a
Forward PE n/a
Dividend 0.20 (1.73%)
Ex-Dividend Date May 29, 2025
Volume 5,004,400
Average Volume 8,426,835
Open 10.68
Previous Close 11.55
Day's Range 10.68 - 11.76
52-Week Range 10.48 - 17.86
Beta 0.58
RSI 51.36
Earnings Date Apr 28, 2026

About SHE:002900

Harbin Medisan Pharmaceutical Co., Ltd. engages in the research, development, production, and sale chemical pharmaceutical preparations in China. The company offers various drugs for nervous system, cardiovascular system, systemic anti-infective, muscle and skeletal system, nutritional infusion, and body fluid balance infusion; and other products, including oxaliplatin for injection, calcium folinate for injection, hydroxylcamptothecine injection, tropisetron hydrochloride for injection, tropisetron hydrochloride and glucose injection, gabexate... [Read more]

Sector Healthcare
Founded 1996
Employees 2,522
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002900
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.